|
1.
|
Thurner B, Haendle I, Roder C, Dieckmann
D, Keikavoussi P, Jonuleit H, Bender A, Maczek C, Schreiner D, von
den Driesch P, Brocker EB, Steinman RM, Enk A, Kampgen E and
Schuler G: Vaccination with mage-3A1 peptide-pulsed mature,
monocyte-derived dendritic cells expands specific cytotoxic T cells
and induces regression of some metastases in advanced stage IV
melanoma. J Exp Med. 190:1669–1678. 1999. View Article : Google Scholar
|
|
2.
|
Godelaine D, Carrasco J, Lucas S,
Karanikas V, Schuler-Thurner B, Coulie PG, Schuler G, Boon T and
Van Pel A: Polyclonal CTL responses observed in melanoma patients
vaccinated with dendritic cells pulsed with a MAGE-3.A1 peptide. J
Immunol. 171:4893–4897. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Morse MA, Garst J, Osada T, Khan S,
Hobeika A, Clay TM, Valente N, Shreeniwas R, Sutton MA, Delcayre A,
Hsu DH, Le Pecq JB and Lyerly HK: A phase I study of dexosome
immunotherapy in patients with advanced non-small cell lung cancer.
J Transl Med. 3:92005. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Chomez P, De Backer O, Bertrand M, De
Plaen E, Boon T and Lucas S: An overview of the MAGE gene family
with the identification of all human members of the family. Cancer
Res. 61:5544–5551. 2001.PubMed/NCBI
|
|
5.
|
Barker PA and Salehi A: The MAGE proteins:
emerging roles in cell cycle progression, apoptosis, and
neurogenetic disease. J Neurosci Res. 67:705–712. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Osterlund C, Tohonen V, Forslund KO and
Nordqvist K: Mage-b4, a novel melanoma antigen (MAGE) gene
specifically expressed during germ cell differentiation. Cancer
Res. 60:1054–1061. 2004.PubMed/NCBI
|
|
7.
|
Sakata M: Expression of MAGE gene family
in lung cancers. Kurume Med J. 43:55–61. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Jang SJ, Soria JC, Wang L, Hassan KA,
Morice RC, Walsh GL, Hong WK and Mao L: Activation of melanoma
antigen tumor antigens occurs early in lung carcinogenesis. Cancer
Res. 61:7959–7963. 2001.PubMed/NCBI
|
|
9.
|
Atanackovic D, Altorki NK, Stockert E,
Williamson B, Jungbluth AA, Ritter E, Santiago D, Ferrara CA,
Matsuo M, Selvakumar A, Dupont B, Chen YT, Hoffman EW, Ritter G,
Old LJ and Gnjatic S: Vaccine-induced CD4+ T cell
responses to MAGE-3 protein in lung cancer patients. J Immunol.
172:3289–3296. 2004.PubMed/NCBI
|
|
10.
|
Fischer C, Gudat F, Stulz P, Noppen C,
Schaefer C, Zajac P, Trutmann M, Kocher T, Zuber M, Harder F,
Heberer M and Spagnoli GC: High expression of MAGE-3 protein in
squamous-cell lung carcinoma. Int J Cancer. 71:1119–1121. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Sienel W, Varwerk C, Linder A, Kaiser D,
Teschne M, Delire M, Stamatis G and Passlick B: Melanoma associated
antigen (MAGE)-A3 expression in stages I and II non-small cell lung
cancer: results of a multi-center study. Eur J Cardiothorac Surg.
25:131–134. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Sugita M, Geraci M, Gao B, Powell RL,
Hirsch FR, Johnson G, Lapadat R, Gabrielson E, Bremnes R, Bunn PA
and Franklin WA: Combined use of oligonucleotide and tissue
microarrays identifies cancer/testis antigens as biomarkers in lung
carcinoma. Cancer Res. 62:3971–3979. 2002.PubMed/NCBI
|
|
13.
|
Tajima K, Obata Y, Tamaki H, Yoshida M,
Chen YT, Scanlan MJ, Old LJ, Kuwano H, Takahashi T, Takahashi T and
Mitsudomi T: Expression of cancer/testis (CT) antigens in lung
cancer. Lung Cancer. 42:23–33. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
De Plaen E, Arden K, Traversari C, et al:
Structure, chromosomal localization, and expression of 12 genes of
the MAGE family. Immunogenetics. 40:360–369. 1994.PubMed/NCBI
|
|
15.
|
Lurquin C, De Smet C, Brasseur F,
Muscatelli F, Martelange V, De Plaen E, Brasseur R, Monaco AP and
Boon T: Two members of the human MAGEB gene family located in
Xp21.3 are expressed in tumors of various histological origins.
Genomics. 46:397–408. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Lucas S, De Smet C, Arden KC, Viars CS,
Lethe B, Lurquin C and Boon T: Identification of a new MAGE gene
with tumor-specific expression by representational difference
analysis. Cancer Res. 58:743–752. 1998.PubMed/NCBI
|
|
17.
|
Gillespie AM and Coleman RE: The potential
of melanoma antigen expression in cancer therapy. Cancer Treat Rev.
25:219–227. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Van den Eynde B, Peeters O, De Backer O,
Gaugler B, Lucas S and Boon T: A new family of genes coding for an
antigen recognized by autologous cytolytic T lymphocytes on a human
melanoma. J Exp Med. 182:689–698. 1995.
|
|
19.
|
Van Baren N, Brasseur F, Godelaine D,
Hames G, Ferrant A, Lehmann F, Andre M, Ravoet C, Doyen C, Spagnoli
GC, Bakkus M, Thielemans K and Boon T: Genes encoding
tumor-specific antigens are expressed in human myeloma cells.
Blood. 94:1156–1164. 1999.PubMed/NCBI
|
|
20.
|
Jungbluth AA, Busam KJ, Kolb D, Iversen K,
Coplan K, Chen YT, Spagnoli GC and Old LJ: Expression of
MAGE-antigens in normal tissues and cancer. Int J Cancer.
85:460–465. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Peikert T, Specks U, Farver C, Erzurum SC
and Comhair SA: Melanoma antigen A4 is expressed in non-small cell
lung cancers and promotes apoptosis. Cancer Res. 66:4693–4700.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Laduron S, Deplus R, Zhou S, Kholmanskikh
O, Godelaine D, De Smet C, Hayward SD, Fuks F, Boon T and De Plaen
E: MAGE-A1 interacts with adaptor SKIP and the deacetylase HDAC1 to
repress transcription. Nucleic Acids Res. 32:4340–4350. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Morishima N, Nakanishi K, Takenouchi H,
Shibata T and Yasuhiko Y: An endoplasmic reticulum stress-specific
caspase cascade in apoptosis. Cytochrome c-independent activation
of caspase-9 by caspase-12. J Biol Chem. 277:34287–34294. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
De Smet C, De Backer O, Faraoni I, Lurquin
C, Brasseur F and Boon T: The activation of human gene MAGE-1 in
tumor cells is correlated with genome-wide demethylation. Proc Natl
Acad Sci USA. 93:7149–7153. 1996.PubMed/NCBI
|
|
25.
|
Gaudet F, Hodgson JG, Eden A,
Jackson-Grusby L, Dausman J, Gray JW, Leonhardt H and Jaenisch R:
Induction of tumors in mice by genomic hypomethylation. Science.
300:489–492. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Eden A, Gaudet F, Waghmare A and Jaenisch
R: Chromosomal instability and tumors promoted by DNA
hypomethylation. Science. 300:4552003. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Bollati V, Baccarelli A, Hou L, Bonzini M,
Fustinoni S, Cavallo D, Byun HM, Jiang J, Marinelli B, Pesatori AC,
Bertazzi PA and Yang AS: Changes in DNA methylation patterns in
subjects exposed to low-dose benzene. Cancer Res. 67:876–880. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Wang L, Wang J, Sun S, Rodriguez M, Yue P,
Jang SJ and Mao L: A novel DNMT3B subfamily, ΔDNMT3B, is the
predominant form of DNMT3B in non-small cell lung cancer. Int J
Oncol. 29:201–207. 2006.
|
|
29.
|
Valinluck V, Tsai HH, Rogstad DK, Burdzy
A, Bird A and Sowers LC: Oxidative damage to methyl-CpG sequences
inhibits the binding of the methyl-CpG binding domain (MBD) of
methyl-CpG binding protein 2 (MeCP2). Nucleic Acids Res.
32:4100–4108. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Mao L, Lee JS, Kurie JM, Fan YH, Lippman
SM, Lee JJ, Ro JY, Broxson A, Yu R, Morice RC, Kemp BL, Khuri FR,
Walsh GL, Hittelman WN and Hong WK: Clonal genetic alterations in
the lungs of current and former smokers. J Natl Cancer Inst.
89:857–862. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Wistuba II, Mao L and Gazdar AF: Smoking
molecular damage in bronchial epithelium. Oncogene. 21:7298–7306.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Peto R, Darby S, Deo H, Silcocks P,
Whitley E and Doll R: Smoking, smoking cessation, and lung cancer
in the UK since 1950: combination of national statistics with two
case-control studies. BMJ. 321:323–329. 2000. View Article : Google Scholar : PubMed/NCBI
|
